Unilab Executive and Leadership Team

Ralph Gray, the Chief Executive Officer at Unilab, directs the overarching corporate strategy for pharmaceutical manufacturing. Gray oversees the alignment of production capabilities with regional market demands across the Philippines. By managing high-level stakeholder relationships, the Chief Executive Officer ensures the organization maintains its competitive edge in the healthcare sector. This leadership role involves constant evaluation of market trends to optimize product distribution and manufacturing efficiency. Ralph Gray drives the long-term vision for the company, focusing on sustainable growth and the expansion of the pharmaceutical portfolio. Through the coordination of various departments, the Chief Executive Officer secures the operational integrity of the entire enterprise. The strategic decisions made by Gray directly influence the availability of essential medicines, reinforcing the company position as a leader in the domestic pharmaceutical industry while fostering innovation in drug development and supply chain management.

Sebastian Baquiran, the President & Chief Executive Officer at Unilab, manages the daily execution of corporate objectives and pharmaceutical manufacturing operations. Baquiran directs the integration of business units to ensure seamless production cycles and consistent quality control. As the President & Chief Executive Officer, Baquiran monitors the performance of manufacturing facilities to meet the healthcare needs of the population. This role requires constant collaboration with the board to refine operational policies and enhance market reach. Sebastian Baquiran drives the implementation of advanced manufacturing technologies to increase output and reduce costs. By overseeing the organizational structure, the President & Chief Executive Officer maintains high standards of excellence in every product line. The leadership provided by Baquiran ensures that the company remains responsive to evolving medical requirements, ultimately supporting the mission to provide affordable and effective pharmaceutical solutions throughout the region.

Luis Vaca, the Chief Financial Officer at Unilab, directs the financial planning, budgeting, and capital allocation strategies for the pharmaceutical manufacturing business. Vaca oversees the fiscal health of the organization, ensuring that resources are directed toward high-impact growth areas. As the Chief Financial Officer, Vaca manages financial reporting and risk assessment to maintain transparency and compliance with industry regulations. This role involves analyzing market data to support strategic investment decisions in new drug development and facility upgrades. Luis Vaca drives the optimization of cost structures to improve profitability while maintaining the affordability of pharmaceutical products. By collaborating with other executives, the Chief Financial Officer ensures that financial goals align with the broader corporate mission. The financial oversight provided by Vaca secures the long-term viability of the company, enabling continued investment in innovation and the expansion of manufacturing capabilities to meet rising healthcare demands.

Rommel Samson, the Chief Financial Officer, Unahco & Division Vice President at Unilab, manages the financial operations and strategic growth of the animal health and nutrition division. Samson directs the budgeting and investment strategies specifically tailored to the unique requirements of the Unahco business unit. As the Chief Financial Officer, Unahco & Division Vice President, Samson oversees the financial performance of product lines to ensure profitability and market expansion. This role involves analyzing sector-specific trends to guide resource allocation and operational improvements. Rommel Samson drives the development of financial models that support the scaling of manufacturing capabilities for animal health products. By aligning division goals with the broader corporate strategy, the Chief Financial Officer, Unahco & Division Vice President ensures consistent growth and operational excellence. The leadership provided by Samson strengthens the company position in the animal health market, contributing to the overall success of the organization.

Noel Cortez, the Chief Operating Officer at Unilab, manages the end-to-end manufacturing processes and supply chain logistics for pharmaceutical products. Cortez directs the daily operations of production facilities to ensure consistent output and quality compliance. As the Chief Operating Officer, Cortez oversees the procurement of raw materials and the distribution of finished goods across the national market. This role involves optimizing manufacturing workflows to maximize efficiency and minimize waste. Noel Cortez drives the adoption of lean manufacturing principles to enhance productivity and maintain competitive pricing. By coordinating with quality assurance teams, the Chief Operating Officer ensures that every product meets strict safety standards. The leadership provided by Cortez supports the company mission by ensuring that essential medicines are consistently available to patients. Through rigorous operational oversight, the Chief Operating Officer maintains the reliability of the supply chain and the overall effectiveness of the manufacturing infrastructure.

Manolet Montinola, the Group President, Ul Health Services, Unilab at Unilab, directs the strategic development and operational management of the health services division. Montinola oversees the expansion of service offerings that complement the core pharmaceutical manufacturing business. As the Group President, Ul Health Services, Unilab, Montinola manages the integration of clinical and wellness services to provide comprehensive healthcare solutions. This role involves building partnerships with healthcare providers to enhance the reach and impact of the company services. Manolet Montinola drives the implementation of service-oriented strategies that improve patient access to quality care. By coordinating with other business units, the Group President, Ul Health Services, Unilab ensures that service delivery aligns with the overall corporate mission. The leadership provided by Montinola expands the company footprint in the healthcare ecosystem, creating new avenues for growth and reinforcing the commitment to improving health outcomes through integrated service and product offerings.

Julio Cortes, the President at Unilab, directs the tactical execution of business plans and the management of key operational divisions. Cortes oversees the alignment of departmental activities with the overarching corporate strategy to ensure consistent performance. As the President, Cortes manages the day-to-day operations of specific business units to drive efficiency and market responsiveness. This role involves fostering collaboration across teams to solve complex manufacturing and distribution challenges. Julio Cortes drives the implementation of performance metrics that track progress toward organizational goals. By providing leadership to various functional areas, the President ensures that the company maintains its high standards of quality and service. The work performed by Cortes supports the long-term vision of the organization, enabling the company to adapt to changing market conditions while maintaining a focus on delivering essential pharmaceutical products to the public with reliability and excellence.

Jennifer Inocentes, the Chief of Staff at Unilab, coordinates executive communications and facilitates the implementation of strategic initiatives across all departments. Inocentes manages the flow of information between the leadership team and operational units to ensure organizational alignment. As the Chief of Staff, Inocentes optimizes internal processes to improve decision-making speed and efficiency. This role involves monitoring the progress of key projects and ensuring that resources are allocated effectively to support pharmaceutical manufacturing goals. Jennifer Inocentes drives the development of internal policies that foster a culture of accountability and excellence. By streamlining administrative functions, the Chief of Staff enables the executive team to focus on long-term growth and market expansion. The work performed by Inocentes directly supports the operational stability of the company, ensuring that all strategic objectives are met with precision and clarity while maintaining the highest standards of corporate governance.

Francisco Ortega, the Chief Information Officer at Unilab, directs the digital transformation and information technology infrastructure supporting pharmaceutical manufacturing. Ortega oversees the implementation of advanced data analytics and enterprise resource planning systems to streamline production and distribution. As the Chief Information Officer, Ortega manages cybersecurity protocols to protect sensitive research and operational data. This role involves integrating digital tools that enhance manufacturing precision and supply chain visibility. Francisco Ortega drives the adoption of cloud-based solutions to improve collaboration across regional facilities. By modernizing the technology stack, the Chief Information Officer ensures that the company remains at the forefront of digital innovation in the pharmaceutical sector. The leadership provided by Ortega supports the overall efficiency of the business, enabling data-driven decision-making that improves product quality and operational speed. Through technological advancement, the Chief Information Officer secures the digital foundation necessary for sustained growth and market competitiveness.